SEC investigating CYDY for public claims about leronlimab for Covid. I made such statements while interim CMO at CYDY and stand by them. I believe leronlimab helps at least some if not many patients critically ill with Covid-19.#SEC#leronlimab#CYDY
I saw yesterday people posting Nader’s email response to a question on DOJ. Probably the email response at this point is vetted by the team and Nader won’t write something independently that breaks the rules. Still shareholders may wish to confirm with the management that it is ok for them to answer and for us to post such answers online before we do so.